Motley Fool Hidden Gems Investing

Motley Fool Hidden Gems Investing

Motley Fool Hidden Gems Investing은 전 세계 주식 투자자들에게 매일의 시장 동향과 심층적인 기업 분석을 제공하는 금융 전문 팟캐스트 프로그램입니다. 이 팟캐스트는 세계적인 투자 자문 기업인 '모틀리 풀(The Motley Fool)'의 투자 분석가들이 직접 참여하여, 단순한 뉴스 전달을 넘어 비즈니스 현안에 대한 장기적인 투자 관점을 제시하는 데 목적을 두고 있습니다.

프로그램의 구성은 크게 주중과 주말 에피소드로 구분됩니다. 월요일부터 금요일까지 이어지는 주중 에피소드에서는 당일 주식 시장에서 가장 주목받는 기업들의 실적 보고, 인수합병 소식, 그리고 거시 경제 지표가 개별 종목에 미치는 영향 등을 집중적으로 분석합니다. 특히 모틀리 풀 특유의 분석 방식인 '장기 보유 및 가치 투자' 철학을 바탕으로, 일시적인 주가 변동성 속에서도 견고한 비즈니스 모델을 가진 기업을 식별하는 방법을 공유합니다.

토요일과 일요일에 공개되는 주말 에피소드는 보다 확장된 주제를 다룹니다. 개인 자산 관리(Personal Finance)와 은퇴 준비를 위한 실무적인 조언은 물론, 경제 분야의 저명한 저술가나 업계 전문가들과의 긴 호흡의 인터뷰를 통해 청취자들에게 다각적인 투자 인사이트를 제공합니다. 이러한 심층 인터뷰 섹션은 특정 산업의 미래 전망이나 자본 시장의 구조적 변화를 이해하는 데 유용한 정보를 포함하고 있습니다.

전체적으로 이 팟캐스트는 초보 투자자부터 숙련된 전문가까지 아우를 수 있는 객관적이고 체계적인 정보를 전달합니다. 복잡한 금융 용어를 명확하게 정의하고, 실제 투자 결정에 참고할 수 있는 구체적인 데이터와 사례 연구를 병행함으로써 청취자가 스스로 비판적인 투자 사고를 기를 수 있도록 돕습니다. 특정 종목에 대한 맹목적인 추천보다는 기업의 펀더멘털을 이해하고 시장의 소음을 걸러내는 통찰력을 기르는 데 중점을 둔 것이 이 프로그램의 핵심적인 특징입니다.

00:00
00:00

에피소드 요약

Two or three day-long sessions a year. Relief from depression symptoms that lasts up to twelve months. A 40% response rate in patients who’ve failed every treatment they’ve tried for the past three to four years. Motley Fool host Sanmeet Deo talks with Kabir Nath, CEO of Compass Pathways — the publicly traded biotech company pioneering psilocybin therapy for treatment-resistant depression and PTSD — about what their phase three clinical data actually shows, how you build a sustainable business when your best case outcome is a patient who barely needs your drug, and why this could be psychiatry’s immuno-oncology moment. Compass Pathways is listed on NASDAQ under the ticker CMPS. Host: Sanmeet Deo Guest: Kabir Nath, CEO of Compass Pathways Producers: Bart Shannon, Lauren Budabin Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within…

에피소드

2426-

The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know

Two or three day-long sessions a year. Relief from depression symptoms that lasts up to twelve months. A 40% response rate in patients who’ve failed every treatment they’ve tried for the past three to four years. Motley Fool host Sanmeet Deo talks with Kabir Nath, CEO of Compass Pathways — the publicly traded biotech company pioneering psilocybin therapy for treatment-resistant depression and PTSD — about what their phase three clinical data actually shows, how you build a sustainable business when your best case outcome is a patient who barely needs your drug, and why this could be psychiatry’s immuno-oncology moment. Compass Pathways is listed on NASDAQ under the ticker CMPS. Host: Sanmeet Deo Guest: Kabir Nath, CEO of Compass Pathways Producers: Bart Shannon, Lauren Budabin Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within…

22 11월 2026
2425-

Is a Japan-Style Downturn Possible in the U.S.?

The Japanese stock market crashed in 1990 and didn’t exceed its previous peak until 2024. Host Robert Brokamp answers a Fool’s question about whether such a long-term bear market could happen in the U.S. Topics discussed:-The history of Japan’s financial asset bubble, which put most other bubbles to shame-The valuation of the U.S. stock market, and what happened the last time stocks were this pricey-Strategies for surviving a longer-term downturn-How the portfolio of someone who retired in 2000 has fared after retiring at the beginning of the worst stretch for U.S. stocks of modern times Host: Robert Brokamp, CFP®, EAEngineer: Bart Shannon Learn more about your ad choices. Visit megaphone.fm/adchoices

21 11월 2026
2424-

Anthropic’s IPO Hangover, Nvidia’s Future Without Jensen, and the Worst Acquisitions Ever

Anthropic’s blockbuster IPO has barely begun trading, but investors are already questioning whether its trillion-dollar valuation can hold up. Travis Hoium, Lou Whiteman, and Jason Moser discuss Nvidia’s leadership transition, growing concerns about AI chip sales to China, and some of the most disastrous acquisitions in corporate history. They also examine the latest consumer earnings and highlight two stocks on their radar. Travis Hoium, Lou Whiteman, and Jason Moser discuss: - Anthropic’s IPO Volatility - Nvidia’s Leadership Transition - China Chip Export Risks - Worst Corporate Acquisitions - Consumer Earnings Check - Stocks on Radar Companies discussed: Anthropic (ANT), Nvidia (NVDA), SpaceX (SPCX), Alphabet (GOOGL), Meta Platforms (META), Microsoft (MSFT), Apple (AAPL), RH (RH), Texas Instruments (TXN), Advanced Micro Devices (AMD), Intuit (INTU), Bending Spoons (BSP), Netflix (NFLX), Verizon (VZ), Alibaba (BABA), Apollo Global Management (APO), Teladoc Health (TDOC), News Corp (NWSA), Mattel (MAT),…

20 11월 2026
2423-

Anthropic Gets a Blockbuster IPO, Take Two Gets a Blockbuster GTA VI Release, EVERYBODY GETS A BLOCKBUSTER!!!

It’s official: Anthropic’s IPO was a resounding success. What was initially targeted to be an $80 billion raise ended up being a $100 billion capital raise, the largest in history (so far). Matt, Jon, and Tyler discuss the monumental IPO and the ripple effects. Plus, Take Two’s release of Grand Theft Auto VI was the largest game launch ever and a mailbag about the effects of the Anthropic IPO on the rest of the market Have a question? Email us; podcasts@fool.com Tyler Crowe, Jon Quast and Matt Frankel discuss:- Anthropic’s record IPO- What do you do with $100 billion, anyways?- What is a PBC- Can GTA VI lead to another golden age for $TTWO’s stock?- Mailbag Companies discussed: ANT, SPCX, PATH, TTWO, AVGO, GOOG, MSFT Host: Tyler CroweGuests: Matt Frankel, Jon QuastEngineer: Bart Shannon Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the…

19 11월 2026
2422-

Can Nvidia Thrive Without Jensen Huang?

Nvidia delivers blockbuster earnings under interim CEO Colette Kress, but investors still have questions about its future without Jensen Huang. Target’s turnaround is gaining momentum as shoppers respond to lower prices, while Waymo faces new regulatory setbacks in California. What do these developments mean for investors navigating AI, consumer spending, and autonomous driving? Travis Hoium, Lou Whiteman, and Rachel Warren discuss: - Nvidia’s Leadership Takes the Stage - Nvidia’s Earnings Impress - Target’s Turnaround Momentum - Consumer Spending Trends - Waymo’s California Freeway Ban - Autonomous Driving Timeline Companies discussed: Nvidia (NVDA), Texas Instruments (TXN), Target (TGT), Nike (NKE), Lululemon Athletica (LULU), Walmart (WMT), TJX Companies (TJX), General Mills (GIS), PepsiCo (PEP), Coca-Cola (KO), Alphabet (GOOGL), Tesla (TSLA), Uber Technologies (UBER) Host: Travis Hoium Guests: Lou Whiteman, Rachel Warren Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for…

18 11월 2026